In Vitro Activities of Tigecycline (GAR-936) against Multidrug-Resistant Staphylococcus aureus and Streptococcus pneumoniae
Open Access
- 1 January 2004
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 48 (1), 366-367
- https://doi.org/10.1128/aac.48.1.366-367.2004
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Résistance des staphylocoques aux antibiotiquesAnnales Françaises dʼAnesthésie et de Réanimation, 2002
- In Vitro Activities of Tigecycline (GAR-936) against Recently Isolated Clinical Bacteria in SpainAntimicrobial Agents and Chemotherapy, 2002
- Glycylcyclines: third-generation tetracycline antibioticsCurrent Opinion in Pharmacology, 2001
- In Vitro Activities of the Glycylcycline GAR-936 against Gram-Positive BacteriaAntimicrobial Agents and Chemotherapy, 2000
- The evolving threat of antibiotic resistance in Europe: new data from the Alexander Project.Journal of Antimicrobial Chemotherapy, 2000
- Penicillin-resistant Streptococcus pneumoniae: selection by both β-lactam and non-β-lactam antibioticsJournal of Antimicrobial Chemotherapy, 1999
- In Vitro and In Vivo Antibacterial Activities of a Novel Glycylcycline, the 9- t -Butylglycylamido Derivative of Minocycline (GAR-936)Antimicrobial Agents and Chemotherapy, 1999
- Decreased Teicoplanin Susceptibility of Methicillin-Resistant Strains of Staphylococcus aureusThe Journal of Infectious Diseases, 1995